FGF23 and hypophosphatemia: Therefore, we made a comprehensive diagnosis of PMT based on the biochemical characteristics of refractory hypophosphatemia, the imaging results of Tc99m-octreotide PET/CT scans, and FGF-23-positive expression on histopathology, after consulting with the MDT team (Figure 6).